東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Reverse engineering industrial bacte...

Lum, Amy Melissa.

Linked to FindBook

Google Book

Amazon

博客來

Reverse engineering industrial bacteria that overproduce antibiotics.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Reverse engineering industrial bacteria that overproduce antibiotics./
Author:	Lum, Amy Melissa.
Description:	103 p.
Notes:	Source: Dissertation Abstracts International, Volume: 66-11, Section: B, page: 6119.
Contained By:	Dissertation Abstracts International66-11B.
Subject:	Engineering, Chemical. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3197472
ISBN:	9780542431715

Reverse engineering industrial bacteria that overproduce antibiotics.
Lum, Amy Melissa.

Reverse engineering industrial bacteria that overproduce antibiotics. - 103 p.

Source: Dissertation Abstracts International, Volume: 66-11, Section: B, page: 6119.

Thesis (Ph.D.)--Stanford University, 2006.

Actinomycetes are an important source of antibiotics and natural products. These compounds are typically produced in small quantities in vivo , making overproducing strains necessary for manufacturing these products. Industrial strains are traditionally acquired through classical strain improvement programs involving years of random mutation and screening. This process is not only time consuming, but the accumulated mutations leading to overproduction are unknown. With the wealth of genomic sequence generated daily, there are now methods to study entire genomes at once, making it feasible to correlate overproduction with genotype. Our research goal was to discover overproduction mechanisms from these industrial strains such that they can be utilized in new strain engineering efforts.

ISBN: 9780542431715Subjects--Topical Terms:

1018531
Engineering, Chemical.

Reverse engineering industrial bacteria that overproduce antibiotics.
LDR:03236nmm 2200301 4500 001 1828167
005 20061228142334.5
008 130610s2006 eng d
020 $a 9780542431715
035 $a (UnM)AAI3197472
035 $a AAI3197472
040 $a UnM $c UnM
100 1 $a Lum, Amy Melissa. $3 1917071
245 1 0 $a Reverse engineering industrial bacteria that overproduce antibiotics.
300 $a 103 p.
500 $a Source: Dissertation Abstracts International, Volume: 66-11, Section: B, page: 6119.
500 $a Adviser: Camilla M. Kao.
502 $a Thesis (Ph.D.)--Stanford University, 2006.
520 $a Actinomycetes are an important source of antibiotics and natural products. These compounds are typically produced in small quantities in vivo , making overproducing strains necessary for manufacturing these products. Industrial strains are traditionally acquired through classical strain improvement programs involving years of random mutation and screening. This process is not only time consuming, but the accumulated mutations leading to overproduction are unknown. With the wealth of genomic sequence generated daily, there are now methods to study entire genomes at once, making it feasible to correlate overproduction with genotype. Our research goal was to discover overproduction mechanisms from these industrial strains such that they can be utilized in new strain engineering efforts.
520 $a To identify potential mechanisms for antibiotic overproduction in existing industrial actinomycete strains, we used DNA microarrays to monitor transcription. In a Saccharopolyspora erythraea erythromycin overproducer from Kosan Biosciences, we found expression of the erythromycin polyketide synthase genes (eryA) was extended four-fold, which may contribute significantly to increased titers. The majority of the erythromycin biosynthetic cluster also followed this expression pattern, suggesting a possible mutation in a dedicated regulator of the cluster.
520 $a A putative regulator, eryR, for the erythromycin biosynthetic cluster was identified by DNA binding gel-shift assays. Increased shift activity in the overproducer strain suggested a connection between this regulator and the gene expression changes of the ery cluster in the overproducer. We purified this protein from crude cell extracts, and obtained peptide sequences through mass-spec de novo sequencing to extract the DNA sequence from the genome. The DNA sequence of eryR encodes an 18 kD protein which is homologous to BldD, a known developmental regulator in Streptomyces coelicolor. When produced heterologously in E. coli, EryR bound all of the erythromycin promoters confirming we had purified a dedicated regulator of the cluster. However, sequence comparison of eryR and its promoter region between the Sac. erythraea overproducer and wildtype strains revealed no mutations, suggesting the mutation causing overproduction may be at a higher level of regulation.
590 $a School code: 0212.
650 4 $a Engineering, Chemical. $3 1018531
650 4 $a Chemistry, Pharmaceutical. $3 550957
690 $a 0542
690 $a 0491
710 2 0 $a Stanford University. $3 754827
773 0 $t Dissertation Abstracts International $g 66-11B.
790 1 0 $a Kao, Camilla M., $e advisor
790 $a 0212
791 $a Ph.D.
792 $a 2006
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3197472